Published in EMBO Reports, the study shows that blocking minor splicing can markedly slow tumor growth in liver, lung and stomach cancers, while leaving healthy cells largely unharmed. The research in animal models and human cells, from Australian medical research…
Continue reading with a subscription
This article is available to subscribers. Subscribe to read it in full, or sign in if you already have an account.